Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply
dc.catalogador | gjm | |
dc.contributor.author | Jara Vallejos, Alejandro Antonio | |
dc.contributor.author | Undurraga Fourcade, Eduardo Andrés | |
dc.contributor.author | Araos, Rafael | |
dc.date.accessioned | 2024-06-26T17:43:11Z | |
dc.date.available | 2024-06-26T17:43:11Z | |
dc.date.issued | 2021 | |
dc.fechaingreso.objetodigital | No aplica | |
dc.fuente.origen | ORCID | |
dc.identifier.doi | 10.1056/NEJMc2112423 | |
dc.identifier.eissn | 15334406 | |
dc.identifier.issn | 1533-4406 | |
dc.identifier.pubmedid | 34525281 | |
dc.identifier.scopusid | SCOPUS_ID:85117739992 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/86869 | |
dc.information.autoruc | Facultad de Matemáticas; Jara Vallejos, Alejandro Antonio; 0000-0002-2282-353X; 127927 | |
dc.information.autoruc | Escuela de Ingeniería; Undurraga Fourcade, Eduardo Andrés; 0000-0002-4425-1253; 12868 | |
dc.issue.numero | 14 | |
dc.language.iso | en | |
dc.nota.acceso | sin adjunto | |
dc.pagina.final | 1339 | |
dc.pagina.inicio | 1338 | |
dc.revista | The New England Journal of Medicine | |
dc.rights | acceso restringido | |
dc.title | Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply | |
dc.type | carta al editor | |
dc.volumen | 385 | |
sipa.codpersvinculados | 127927 | |
sipa.codpersvinculados | 12868 | |
sipa.trazabilidad | ORCID;2024-06-24 |